Table 4. Crude and age-adjusted 5- and 10-year relative survival of patients diagnosed with common forms of cancer above 14 years of age in Finland in 1989.

	5-year relative survival					10-year relative survival
		Age adjusted					Age adjusted
		PE		s.e.			PE		s.e.
Cancer site	Crude	T	A	T	A	Crude	T	A	T	A
Oral cavity	61.5	61.2	61.1	3.04	3.13	54.5	52.9	54.8	3.59	3.58
Stomach	22.8	22.0	22.9	1.52	1.54	23.7	23.3	23.7	2.13	1.84
Colon	52.3	51.0	51.4	2.07	1.97	52.1	52.0	50.9	2.97	2.41
Rectum	45.0	43.9	45.1	2.49	2.46	42.4	40.9	42.6	3.29	2.89
Pancreas	1.8	1.4	1.7	0.47	0.56	1.9	1.2	1.8	0.46	0.69
Lung	10.0	9.5	10.2	0.75	0.79	7.5	6.3	7.6	0.68	0.79
Breast	80.8	80.6	80.7	1.05	0.95	70.8	69.6	70.6	1.47	1.18
Cervix	57.6	65.4	67.4	4.17	4.28	59.0	62.9	67.0	4.47	4.57
Corpus	73.7	75.0	76.5	2.06	2.03	73.0	72.6	74.8	2.71	2.49
Ovaries	37.3	37.9	39.1	2.42	2.45	33.0	31.6	34.7	2.52	2.56
Prostate	62.9	64.1	63.4	2.23	1.99	44.5	44.7	44.8	3.55	2.47
Kidneys	54.6	54.3	55.3	2.44	2.40	50.0	48.4	50.6	2.99	2.76
Urinary bladder	66.1	64.8	66.7	2.52	2.41	59.0	53.0	59.7	3.27	2.94
Melanoma	81.4	81.5	82.2	2.19	2.09	77.8	77.0	78.5	3.05	2.55
Thyroid gland	84.5	80.0	82.7	2.74	2.41	87.9	80.7	86.7	3.58	2.67

Age adjustment is made to the site-specific EUROCARE-2 standard population. Point estimates (PE) and their standard errors (s.e.) obtained by bootstrap analyses with 10 000 replications are given for age adjustment by the traditional method (T) and by the alternative method (A).